Pregnancy-enhanced Ca2+ responses to ATP in uterine artery endothelial cells is due to greater capacitative Ca2+ entry rather than altered receptor coupling

Journal of Endocrinology

Volumn 190, Issue 2, 2006, Pages 373-384

  Gifford, Shannon M ^a   Yi, Fu Xian ^a   Bird, Ian M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHOLIPASE C; PURINE P2X1 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y6 RECEPTOR; PURINE RECEPTOR; RECEPTOR SUBTYPE; THAPSIGARGIN; URIDINE TRIPHOSPHATE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LYSATE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE ARTERY; VASODILATATION; ANIMAL; ANIMAL MODEL; ARTERY; FLUORESCENCE MICROSCOPY; METABOLISM; METHODOLOGY; PHYSIOLOGY; SHEEP; UTERUS; VASCULAR ENDOTHELIUM; VASCULARIZATION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARTERIES; BLOTTING, WESTERN; CALCIUM; CALCIUM SIGNALING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GTP-BINDING PROTEINS; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; PREGNANCY; RECEPTORS, PURINERGIC; SHEEP; UTERUS;

EID: 33747872587     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06635     Document Type: Article

References (24)

1. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J & Magness RR 2000 Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 141 1107-1117.
2. Bird IM, Zhang L & Magness RR 2003 Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. American Journal of Physiology 284 R245-R258.
3. 2+ release. FASEB Journal 16 1145-1150.
4. Communi D, Janssens R, Suarez-Huerta N, Robaye B & Boeynaems J-M 2000 Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors. Cellular Signalling 12 351-360.
5. Costanzi S, Mamedova L, Gao Z-G &Jacobson KA 2004 Architecture of P2Y nucleoticle receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. Journal of Medicinal Chemistry 47 5393-5404.
6. 2+ sensitivity of endothelial nitric oxide synthase as well as cytosolic phospholipase A2. Endocrinology 142 3014-3026.
7. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, Zhang XJ, Clark DA & Miller MJ 1994 Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. American Journal of Obstetrics and Gynecology 171 1243-1250.
8. Fitzgerald DJ, Entman SS, Mulloy K & Fitzgerald GA 1987 Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 75 956-963.
9. Gifford SM, Cale JM, Tsoi S, Magness RR & Bird IM 2003 Pregnancy-specific changes in uterine artery endothelial cell signaling in vivo are both programmed and retained in primary culture. Endocrinology 144 3639-3650.
10. Goodman RP, Killam AP, Brash AR & Branch RA 1982 Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. American Journal of Obstetrics and Gynecology 142 817-822.
11. Kunapuli SP & Daniel JL 1998 P2 Receptor subtypes in the cardiovascular system. Biochemical Journal 336 513-523.
12. 2+ release. Japanese Journal of Biochemistry 122 498-505.
13. Murthy KS & Makhlouf GM 1998 Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Journal of Biological Chemistry 273 4695-4704.
14. Putney JW Jr 1986 A model for receptor-regulated calcium entry. Cell Calcium 7 1-12.
15. Ralevic V & Burnstock G 1998 Receptors for purines and pyrimidines. Pharmacology Reviews 50 413-492.
16. 2+ mobilization in bovine corneal endothelial cells by P2 purinergic receptors. Current Eye Research 17 994-1004.
17. Strassheim D & Williams CL 2000 P2Y2 Purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-β isoforms that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. Journal of Biological Chemistry 275 39767-39772.
18. 2+ U0126, and wortmannin but not LY29 4002-evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling. Endocrinology 147 2442-2457.
19. 2+ dependent manner. Life Sciences 72 1445-1453.
20. Tran Q-K, Ohashi K & Watanabe H 2000 Calcium signalling in endothelial cells. Cardiovascular Research 48 13-22.
21. Vassort G 2001 Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Pharmacology Reviews 81 767-806.
22. von Kügelgen I & Wetter A 2000 Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 362 310-323.
23. Wang L, Karlsson L, Moses S, Hulgårdt-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S & Erlinge D 2002 P2 Receptor expression profiles in human vascular smooth muscle and endothelial cells. Journal of Cardiovascular Pharmacology 40 841-853.
24. 2+ of human cardiac endothelial cells. Pharmacology and Toxicology 85 7-15.